Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 46 AL 60

APOE genotype and brain development

Growdon JH, Hyman BT.

JAMA Neurol. 2014 Jan;71(1):7-8. doi: 10.1001/jamaneurol.2013.5200.

Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study

Dean DC 3rd, Jerskey BA, Chen K, Protas H, Thiyyagura P, Roontiva A, O'Muircheartaigh J, Dirks H, Waskiewicz N, Lehman K, Siniard AL, Turk MN, Hua X, Madsen SK, Thompson PM, Fleisher AS, Huentelman MJ, Deoni SC, Reiman EM.

JAMA Neurol. 2014 Jan;71(1):11-22. doi: 10.1001/jamaneurol.2013.4544.

Gender-related association of brain-derived neurotrophic factor gene 196A/G polymorphism with Alzheimer's disease--a meta-analysis including 6854 cases and 6868 controls

Chen J, Liang X, Li B, Jiang X, Xu Z.

Int J Neurosci. 2014 Oct;124(10):724-33. doi: 10.3109/00207454.2013.869594. Epub 2014 Jan 7.

The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease

Mitolo M, Salmon DP, Gardini S, Galasko D, Grossi E, Caffarra P.

J Alzheimers Dis. 2014;39(4):823-32. doi: 10.3233/JAD-131403.

Facilitating Alzheimer disease research recruitment

Grill JD, Galvin JE.

Alzheimer Dis Assoc Disord. 2014 Jan-Mar;28(1):1-8. doi: 10.1097/WAD.0000000000000016.

Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease

Baptista FI, Henriques AG, Silva AM, Wiltfang J, da Cruz e Silva OA.

ACS Chem Neurosci. 2014 Feb 19;5(2):83-92. doi: 10.1021/cn400213r. Epub 2014 Jan 3.

Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis

Wood WG, Li L, Müller WE, Eckert GP.

J Neurochem. 2014 May;129(4):559-72. doi: 10.1111/jnc.12637. Epub 2014 Jan 2.

Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2

Vandal M, Alata W, Tremblay C, Rioux-Perreault C, Salem N Jr, Calon F, Plourde M.

J Neurochem. 2014 May;129(3):516-26. doi: 10.1111/jnc.12640. Epub 2014 Jan 29.

A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease

Grove RA, Harrington CM, Mahler A, Beresford I, Maruff P, Lowy MT, Nicholls AP, Boardley RL, Berges AC, Nathan PJ, Horrigan JP.

Curr Alzheimer Res. 2014 Jan;11(1):47-58. doi: 10.2174/1567205010666131212110148.

Wnt/β-catenin signaling in Alzheimer's disease

De Ferrari GV, Avila ME, Medina MA, Perez-Palma E, Bustos BI, Alarcon MA.

CNS Neurol Disord Drug Targets. 2014;13(5):745-54. doi: 10.2174/1871527312666131223113900.

Systematic review of the effects of exercise on activities of daily living in people with Alzheimer's disease

Rao AK, Chou A, Bursley B, Smulofsky J, Jezequel J.

Am J Occup Ther. 2014 Jan-Feb;68(1):50-6. doi: 10.5014/ajot.2014.009035.

Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease

Aliev G, Priyadarshini M, Reddy VP, Grieg NH, Kaminsky Y, Cacabelos R, Ashraf GM, Jabir NR, Kamal MA, Nikolenko VN, Zamyatnin AA Jr, Benberin VV, Bachurin SO.

Curr Med Chem. 2014;21(19):2208-17. doi: 10.2174/0929867321666131227161303.

Associations between serum cholesterol levels and cerebral amyloidosis

Reed B, Villeneuve S, Mack W, DeCarli C, Chui HC, Jagust W.

JAMA Neurol. 2014 Feb;71(2):195-200. doi: 10.1001/jamaneurol.2013.5390.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias